copy and paste this google map to your website or blog!
Press copy button and paste into your blog or website.
(Please switch to 'HTML' mode when posting into your blog. Examples: WordPress Example, Blogger Example)
Home | GSK US Meet Shreya: From hot pink goggles to scientist Shreya shares her journey from when she was a little girl in Science in Summer to having a career at GSK today
Products - GSK US Unfortunately, we cannot provide comprehensive information about our products here, in compliance with regulations If you are a healthcare professional, you can access more product information on our GSKPro website In the US, if you are a patient and have questions about our medicines, please contact the GSK Response Center
Inclusion | GSK US To be a successful business and deliver positive health impact at scale, we must meet patients’ needs with research that includes those impacted by the disease under study, attract and retain the best talent regardless of background, and support all GSK people to thrive
Vaccines | GSK US The vaccines in our portfolio have been helping to protect people from serious disease for well over 100 years, with our Marietta, PA site dedicated to smallpox vaccine production since 1882 Today, our vaccines continue to make an impact for society by tackling some of the world’s most devastating diseases, including pneumococcal disease, meningitis, hepatitis, rotavirus, whooping cough and
Careers | GSK US At GSK, we unite science, technology and talent to get ahead of disease together We aim to positively impact the health of 2 5 billion people by the end of the decade, as a successful, growing company where people can thrive
GSK invests $120 million in next-generation US biopharmaceutical . . . GSK today announced a $120 million investment to expand its manufacturing facility in Upper Merion, Pennsylvania that will support the delivery of the company’s pipeline, bringing new medicines for cancer and other specialty diseases to patients faster
Therapeutic areas - GSK US Explore innovations in medicines and healthcare from inside and outside our labs Discover more about what we do, the people behind GSK and how we operate responsibly for all our stakeholders by prioritizing Innovation, Performance and Trust
GSK announces cap of $35 per month on U. S. patient out-of-pocket costs . . . GSK will share specific details closer to implementation Today’s announcement builds on GSK’s strong track record of increasing access and improving the affordability of its medicines, including an ongoing commitment to responsible pricing